 Start your search |
| Carcinogens and mutagens |
| Reproductive toxicants |
| Endocrine disruptors |
| Neurotoxicants |
| Ototoxicants |
| Sensitizers |
| PBT and vPvB substances |
| Aquatic toxicity |
| Chemicals harmful to the atmosphere |
| Persistent Organic Pollutants (POP) |
| Substance linked with Occupational diseases |
| Volatile organic compounds (VOCs) |
| Plant Protection Products (PPP) or pesticides |
| Biocides |
| Restricted chemicals |
| Substances under evaluation, candidate substances and substances subject to the authorisation process under REACH regulation |
| Soil pollutants |
This site has been developed by ISTAS - CC.OO.
| Reproductive toxicants | Go to: What is a reproductive toxicant? What to do? Classification Related legislation and policies References List of substances |
| What is a reproductive toxicant? |  |
A reproductive toxicant or reprotoxicant will impair the ability to get children or cause irreversible harm to the offspring itself. Alterations include miscarriages, damage to unborn children’s development, alteration of breastfeeding capability, or negative inherited developmental effects. Legislation differentiates substances that are toxic for fertility and substances that damage development: Toxic for fertility are substances and compounds that may alter sexual behaviour reducing libido, causing erectile dysfunction and altering menstrual cycles. They can also damage ova and affect the quality of sperm or cause disorders in human reproductive organs. Developmental toxicity is associated with substances and compounds that can cause fatal damage to the unborn child, developmental disorders, innate disorders and childhood and adult health diseases due to prenatal exposure. Toxic substances on or via lactation can affect both mothers’ milk and breastfeeding children. They may also affect female workers’ by impairing their capability to breastfeed, reducing their milk production (endocrine disruptors) or passing on toxins to the babies. They are classified as substances of high concern in order to warn breastfeeding mothers about this specific hazard.
- Former Dangerous Substances Directive, so called DSD (67/548/EEC) and the new Regulation 1272/2008 (CLP) identify reprotoxic substances with the following risk phrases (R) and hazard statements (H):
A) Substances which cause adverse effects on
sexual function and fertility; According to DSD:
- R60: May impair fertility
- R62: Possible risk of impaired fertility
According to CLP:
- H360F: 1B: May damage fertility
- H360FD: May damage fertility. May damage the unborn child.
- H360Fd: May damage fertility. Suspected of damaging the unborn child.
- H361f: Suspected of damaging fertility.
- H361fd: Suspected of damaging fertility. Suspected of damaging the unborn child.
B) Substances which cause adverse effects on
development of the offspring: According to DSD:
- R61: May cause harm to the unborn child
- R63: Possible risk of harm to the unborn child.
According to CLP:
- H360D: May damage the unborn child.
- H360FD: May damage fertility. May damage the unborn child.
- H360Df: May damage the unborn child. Suspected of damaging fertility.
- H361d: Suspected of damaging the unborn child.
- H361fd: Suspected of damaging fertility. Suspected of damaging the unborn child
C) Substances which cause adverse effects on or via
lactation: According to DSD:
- R64 May cause harm to breastfed babies
According to CLP:
- H362 May cause harm to breast-fed children.
| What to do? | |
Given the serious effects of exposure to these agents they are classified as highly hazardous chemicals and risks from exposure must be avoided. Their elimination or substitution are priority actions and only in those cases where these actions are not technically feasible, workers’ exposure must be reduced through other measures (individual and collective protection) following the principles of preventive action according to Directive 89/391/EEC on the introduction of measures to encourage improvements in the safety and health of workers at work. In view of the possibility of exposure of pregnant or breastfeeding women’s employers must:
- Implement the necessary measures to avoid exposure by adapting the workplaces of affected workers.
- Transfer the affected workers to work stations compatible with their condition whenever modification of workplaces is not possible.
- Suspend the affected workers’ from their jobs during pregnancy or breastfeeding periods whenever transfer to other work stations is not possible. This option includes subsidizing affected workers (subsidized job suspension)
| Classification | |
- Regulation 1272/2008 (CLP), in force since January 20th 2009, on classification, labelling and packing of substances and compounds, classifies substances toxic for reproduction as follows:
Hazard categories for reproductive toxicants
| CATEGORY 1 Category 1A and Category 1B |
CATEGORY 1 Known or presumed human reproductive toxicant. Substances are classified in Category 1 for reproductive toxicity when they are known to have produced an adverse effect on sexual function and fertility, or on development in humans or when there is evidence from animal studies, possibly supplemented with other information, to provide a strong presumption that the substance has the capacity to interfere with reproduction in humans. The classification of a substance is further distinguished on the basis of whether the evidence for classification is primarily from human data (Category 1A) or from animal data (Category 1B). Category 1A Known human reproductive toxicant. The classification of a substance in Category 1A is largely based on evidence from humans. Category 1B Presumed human reproductive toxicant. The classification of a substance in Category 1B is largely based on data from animal studies. Such data shall provide clear evidence of an adverse effect on sexual function and fertility or on development in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. However, when there is mechanistic information that raises doubt about the relevance of the effect for humans, classification in Category 2 may be more appropriate. |  Danger |
| H360: May damage fertility or the unborn child (state specific effect if known)(state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) |
| CATEGORY 2 |
Suspected human reproductive toxicant Substances are classified in Category 2 for reproductive toxicity when there is some evidence from humans or experimental animals, possibly supplemented with other information, of an adverse effect on sexual function and fertility, or on development, and where the evidence is not sufficiently convincing to place the substance in Category 1. If deficiencies in the study make the quality of evidence less convincing, Category 2 could be the more appropriate classification. Such effects shall have been observed in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of the other toxic effects. | Warning |
| H361: Suspected of damaging fertility or the unborn child (state specific effect if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) |
Hazard category for lactation effects
| EFFECTS ON OR VIA LACTATION |
Effects on or via lactation are allocated to a separate single category. It is recognised that for many substances there is no information on the potential to cause adverse effects on the offspring via lactation. However, substances which are absorbed by women and have been shown to interfere with lactation, or which may be present (including metabolites) in breast milk in amounts sufficient to cause concern for the health of a breastfed child, shall be classified and labelled to indicate this property hazardous to breastfed babies. This classification can be assigned on the: (a) human evidence indicating a hazard to babies during the lactation period; and/or (b) results of one or two generation studies in animals which provide clear evidence of adverse effect in the offspring due to transfer in the milk or adverse effect on the quality of the milk; and/or (c) absorption, metabolism, distribution and excretion studies that indicate the likelihood that the substance is present in potentially toxic levels in breast milk. H362: May cause harm to breast-fed children. |
- Former Directive 67/548/EEC relating to the classification, packaging and labelling of dangerous substances.(in force until 1st December of 2010, with the exemption of substances already in the market before the cited date, for these substances, there will be no obligation to re-label or repackage until 1st December, 2012).
According to DSD reprotoxicant substances are divided into 3 categories:
| Category 1 |
Substances known to impair fertility in humans. There is sufficient evidence to establish a causal relationship between human exposure to the substance and impaired fertility. |  T: Toxic |
| R60: May impair fertility |
Substances known to cause developmental toxicity in humans. There is sufficient evidence to establish a causal relationship between human exposure to the substance and subsequent developmental toxic effects in the progeny. | T: Toxic |
| R61: May cause harm to the unborn child |
| Category 2 |
Substances which should be regarded as if they impair fertility in humans. There is sufficient evidence to provide a strong presumption that human exposure to the substance may result in impaired fertility on the basis of: - clear evidence in animal studies of impaired fertility in the absence of toxic effects, or, evidence of impaired fertility occurring at around the same dose levels as other toxic effects but which is not a secondary nonspecific consequence of the other toxic effects,
- other relevant information.
| T: Toxic |
| R60 May impair fertility |
Substances which should be regarded as if they cause developmental toxicity to humans. There is sufficient evidence to provide a strong presumption that human exposure to the substance may result in developmental toxicity, generally on the basis of: - clear results in appropriate animal studies where effects have been observed in the absence of signs of marked maternal toxicity, or at around the same dose levels as other toxic effects but which are not a secondary non-specific consequence of the other toxic effects,
- other relevant information.
| T: Toxic |
| R61 May cause harm to the unborn child |
| Category 3 |
Substances which cause concern for human fertility Generally on the basis of: - results in appropriate animal studies which provide sufficient evidence to cause a strong suspicion of impaired fertility in the absence of toxic effects, or evidence of impaired fertility occuring at around the same dose levels as other toxic effects, but which is not a secondary non-specific consequence of the other toxic effects, but where the evidence is insufficient to place the substance in Category 2,
- other relevant information.
|  Xn: Harmful |
| R62 Possible risk of impaired fertility |
Substances which cause concern for humans owing to possible developmental toxic effects Generally on the basis of: - results in appropriate animal studies which provide sufficient evidence to cause a strong suspicion of developmental toxicity in the absence of signs of marked maternal toxicity, or at around the same dose levels as other toxic effects but which are not a secondary non-specific consequence of the other toxic effects, but where the evidence is insufficient to place the substance in Category 2,
- other relevant information.
| Xn: Harmful |
| R63 Possible risk of harm to the unborn child. |
Hazard category for adverse effects on or via lactancy
| Effects during lactation |
Substances which are classified as toxic to reproduction and which also cause concern due to their effects on lactation should in addition be labelled with R64. For the purpose of classification, toxic effects on offspring resulting only from exposure via the breast milk, or toxic effects resulting from direct exposure of children will not be regarded as "Toxic to reproduction`, unless such effects result in impaired development of the offspring. Substances which are not classified as toxic to reproduction but which cause concern due to toxicity when transferred to the baby during the period of lactation should be labelled with R64. This R-phrase may also be appropriate for substances which affect the quantity or quality of the milk. R64 would normally be assigned on the basis of : (a) toxicokinetic studies that would indicate the likelihood that the substance would be present in potentially toxic levels in breast milk; and/or (b) on the basis of results of one or two generation studies in animals which indicate the presence of adverse effects on the offspring due to transfer in the milk; and/or (c) on the basis of evidence in humans indicating a risk to babies during the lactation period. Substances which are known to accumulate in the body and which subsequently may be released into milk during lactation may be labelled with R33 and R64. |
| Related legislation and policies | |
- Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work
- Regulation 1272/2008 (CLP) on classification, labelling and packaging of substances and mixtures.
- Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances.
- Council Directive 98/24/ECTP of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical agents at work.
- Council Directive 92/85/EEC of 19 October 1992 concerning the implementation of measures to encourage improvements in the safety and health of pregnant workers, workers who have recently given birth and women who are breastfeeding (Tenth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC)
| References | |
The sources consulted for the preparation of this list are:
| List | Source | Publication date |
Regulation 1272/2008 (CLP) | Annexes I, VI and VII | January 2011 |
| Directive 67/548/EEC (DSD) | Annexes I and IV | June 2011 |
| Directive 89/391/EEC | Directive 89/391/EEC | November 2005 |
| Last update | |
July 2012 
This web has been developed by SPL Sistemas de Información
We use cookies analytics and similar technologies on our web site to improve performance and web browsing. Continuing to use our web site indicates your consent to their use
For more information please consult our privacy policy.